Lumidex Path
Payments companies reported to CMS as associated with Lumidex Path. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lumidex Path, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lumidex Path
These are the largest totals companies reported as associated with Lumidex Path. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| James Humphreys | San Antonio, TX | Anatomic Pathology & Clinical Pathology | $150.00 |
| James Kwon | Tripler Amc, HI | Anatomic Pathology & Clinical Pathology | $150.00 |
| Dana Altenburger | Normal, IL | Anatomic Pathology & Clinical Pathology | $150.00 |
| Jeffrey Eisenstein | Ocala, FL | Anatomic Pathology & Clinical Pathology | $150.00 |
| Angela Konrad | Mason City, IA | Anatomic Pathology & Clinical Pathology | $150.00 |
Prescribed Lumidex Path?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.